Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer- Early Detection of Cancer Disease and Pre-Cancer Disease, and in Women That Are at High Risk for Developing Breast Cancer by Identifying Lymphocytes Previously Exposed to Specific Cancer Antigen.

NCT00407706 is registered in ClinicalTrials.gov with Ziv Hospital as lead sponsor.

NCT NCT00407706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer- Early Detection of Cancer Disease and Pre-Cancer Disease, and in Women That Are at High Risk for Developing Breast Cancer by Identifying Lymphocytes Previously Exposed to Specific Cancer Antigen.
Lead sponsor
Ziv Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2006
Completion date
December 31, 2010
Enrollment
180
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant breast cancer, benign breast lesions